CA2788582C - Nitric oxide delivery system - Google Patents
Nitric oxide delivery system Download PDFInfo
- Publication number
- CA2788582C CA2788582C CA2788582A CA2788582A CA2788582C CA 2788582 C CA2788582 C CA 2788582C CA 2788582 A CA2788582 A CA 2788582A CA 2788582 A CA2788582 A CA 2788582A CA 2788582 C CA2788582 C CA 2788582C
- Authority
- CA
- Canada
- Prior art keywords
- gas
- nitrogen dioxide
- reservoir
- tube
- nitric oxide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title claims abstract description 280
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 claims abstract description 118
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 claims abstract description 112
- 239000007788 liquid Substances 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 21
- 239000007789 gas Substances 0.000 claims description 84
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 40
- 239000001301 oxygen Substances 0.000 claims description 40
- 229910052760 oxygen Inorganic materials 0.000 claims description 40
- WFPZPJSADLPSON-UHFFFAOYSA-N dinitrogen tetraoxide Chemical compound [O-][N+](=O)[N+]([O-])=O WFPZPJSADLPSON-UHFFFAOYSA-N 0.000 claims description 29
- 239000003963 antioxidant agent Substances 0.000 claims description 19
- 230000003078 antioxidant effect Effects 0.000 claims description 19
- 235000006708 antioxidants Nutrition 0.000 claims description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 18
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 18
- 229910001882 dioxygen Inorganic materials 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 12
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 12
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical class [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 10
- 239000011149 active material Substances 0.000 claims description 10
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 10
- 230000001225 therapeutic effect Effects 0.000 claims description 10
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 9
- 235000010323 ascorbic acid Nutrition 0.000 claims description 9
- 239000011668 ascorbic acid Substances 0.000 claims description 9
- 229960005070 ascorbic acid Drugs 0.000 claims description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 8
- 229920006395 saturated elastomer Polymers 0.000 claims description 8
- 229940087168 alpha tocopherol Drugs 0.000 claims description 6
- 239000003085 diluting agent Substances 0.000 claims description 6
- 235000010382 gamma-tocopherol Nutrition 0.000 claims description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 239000000741 silica gel Substances 0.000 claims description 6
- 229910002027 silica gel Inorganic materials 0.000 claims description 6
- 229960000984 tocofersolan Drugs 0.000 claims description 6
- 235000004835 α-tocopherol Nutrition 0.000 claims description 6
- 239000002076 α-tocopherol Substances 0.000 claims description 6
- 239000002478 γ-tocopherol Substances 0.000 claims description 6
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 claims description 6
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 2
- 210000004072 lung Anatomy 0.000 description 10
- 206010021143 Hypoxia Diseases 0.000 description 8
- 230000004044 response Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 208000002815 pulmonary hypertension Diseases 0.000 description 5
- 241000124008 Mammalia Species 0.000 description 4
- 239000003638 chemical reducing agent Substances 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 208000018875 hypoxemia Diseases 0.000 description 4
- 230000007954 hypoxia Effects 0.000 description 4
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000004872 arterial blood pressure Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 230000004962 physiological condition Effects 0.000 description 3
- 210000001147 pulmonary artery Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 2
- 208000004248 Familial Primary Pulmonary Hypertension Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000010378 Pulmonary Embolism Diseases 0.000 description 2
- 241000277284 Salvelinus fontinalis Species 0.000 description 2
- 241001116459 Sequoia Species 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 238000001949 anaesthesia Methods 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000000693 micelle Substances 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 230000036581 peripheral resistance Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 238000002627 tracheal intubation Methods 0.000 description 2
- 230000024883 vasodilation Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000010444 Acidosis Diseases 0.000 description 1
- 206010001029 Acute pulmonary oedema Diseases 0.000 description 1
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 1
- 206010003504 Aspiration Diseases 0.000 description 1
- 208000003241 Fat Embolism Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000034388 Mountain sickness acute Diseases 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 206010064911 Pulmonary arterial hypertension Diseases 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000005279 Status Asthmaticus Diseases 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 208000018315 acute mountain sickness Diseases 0.000 description 1
- 208000011341 adult acute respiratory distress syndrome Diseases 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 206010006475 bronchopulmonary dysplasia Diseases 0.000 description 1
- 238000007675 cardiac surgery Methods 0.000 description 1
- 235000019506 cigar Nutrition 0.000 description 1
- 239000000571 coke Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003434 inspiratory effect Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000009984 peri-natal effect Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 201000008312 primary pulmonary hypertension Diseases 0.000 description 1
- 229940048914 protamine Drugs 0.000 description 1
- 230000008695 pulmonary vasoconstriction Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/021—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes operated by electrical means
- A61M16/022—Control means therefor
- A61M16/024—Control means therefor including calculation means, e.g. using a processor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
- A61M16/10—Preparation of respiratory gases or vapours
- A61M16/1005—Preparation of respiratory gases or vapours with O2 features or with parameter measurement
- A61M2016/102—Measuring a parameter of the content of the delivered gas
- A61M2016/1035—Measuring a parameter of the content of the delivered gas the anaesthetic agent concentration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0208—Oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/02—Gases
- A61M2202/0266—Nitrogen (N)
- A61M2202/0275—Nitric oxide [NO]
Landscapes
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30042510P | 2010-02-01 | 2010-02-01 | |
| US61/300,425 | 2010-02-01 | ||
| PCT/US2011/023172 WO2011094684A1 (en) | 2010-02-01 | 2011-01-31 | Nitric oxide delivery system |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2788582A1 CA2788582A1 (en) | 2011-08-04 |
| CA2788582C true CA2788582C (en) | 2020-01-07 |
Family
ID=44319849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2788582A Active CA2788582C (en) | 2010-02-01 | 2011-01-31 | Nitric oxide delivery system |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110240019A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2531249B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5965845B2 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011210543B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2788582C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2873089T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2011094684A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7618594B2 (en) * | 2004-08-18 | 2009-11-17 | Geno Llc | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| AU2005277397B2 (en) | 2004-08-18 | 2011-08-25 | VERO Biotech LLC. | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| JP5554723B2 (ja) | 2008-01-28 | 2014-07-23 | ゲノ エルエルシー | 二酸化窒素（ｎｏ２）から一酸化窒素（ｎｏ）への変換 |
| US8607785B2 (en) | 2008-08-21 | 2013-12-17 | Geno Llc | Systems and devices for generating nitric oxide |
| EP2445508B1 (en) | 2009-06-22 | 2018-11-14 | VERO Biotech LLC | Nitric oxide therapies |
| WO2012075420A1 (en) | 2010-12-03 | 2012-06-07 | Geno Llc | Nitric oxide treatments |
| AU2013257484B2 (en) * | 2011-01-06 | 2017-09-28 | Mallinckrodt Hospital Products IP Limited | Nitric oxide delivery device |
| PT2661300T (pt) | 2011-01-06 | 2017-12-26 | Ino Therapeutics Llc | Dispositivo e sistema de distribuição de gás |
| CA2838829A1 (en) * | 2011-06-10 | 2012-12-13 | Geno Llc | Pressurized vessel of nitric oxide (no) |
| EP2822566A4 (en) | 2012-03-07 | 2015-08-05 | Advanced Inhalation Therapies Ait Ltd | INHALATION OF STICK OXIDE FOR THE TREATMENT OF RESPIRATORY DISEASES |
| WO2013138654A1 (en) * | 2012-03-15 | 2013-09-19 | Ino Therapeutics Llc | Methods of administering high concentrations of nitric oxide |
| US9423051B2 (en) * | 2012-08-17 | 2016-08-23 | The Coca-Cola Company | Dispensing carbonated beverages from a closed package |
| JP2016500550A (ja) * | 2012-11-05 | 2016-01-14 | ゲノ エルエルシー | 一酸化窒素を含むガスを混合する方法 |
| EP2964302A2 (en) | 2013-03-07 | 2016-01-13 | Advanced Inhalation Therapies (AIT) Ltd. | Inhalation of nitric oxide for treating respiratory diseases |
| ES2774711T3 (es) * | 2013-03-13 | 2020-07-22 | Mallinckrodt Hospital Products Ip Ltd | Dispositivos para supervisar la oxigenación durante el tratamiento con administración de óxido nítrico |
| JP6072611B2 (ja) * | 2013-05-28 | 2017-02-01 | 住友精化株式会社 | 二酸化窒素の変換方法および二酸化窒素変換装置 |
| US10525226B2 (en) * | 2014-05-14 | 2020-01-07 | Mallinckrodt Hospital Products IP Limited | Systems and methods for indicating lifetime of an NO2-to-NO reactor cartridge used to deliver NO for inhalation therapy to a patient |
| EP3302277A4 (en) * | 2015-05-25 | 2019-01-02 | VERO Biotech LLC | Nitric oxide treatment system and method |
| EP3334484B1 (en) * | 2015-08-12 | 2024-12-25 | The General Hospital Corporation | Compositions that promote hypoxia or the hypoxia response for the treatment and prevention of mitochondrial dysfunction |
| KR102835088B1 (ko) | 2015-10-01 | 2025-07-17 | 말린크로트 파마슈티칼스 아일랜드 리미티드 | 흡입 치료 가스로 고농도 no를 확산시키는 장치 및 방법 |
| WO2017100731A1 (en) * | 2015-12-11 | 2017-06-15 | Geno Llc | Method and apparatus for administering gases including nitric oxide to address fibrosis |
| MX2020010523A (es) | 2017-02-27 | 2021-02-09 | Third Pole Inc | Sistemas y metodos para generar oxido nitrico. |
| CN113620263A (zh) | 2017-02-27 | 2021-11-09 | 第三极股份有限公司 | 生成一氧化氮的系统和方法 |
| MX2019009931A (es) | 2017-02-27 | 2020-07-14 | Third Pole Inc | Sistemas y metodos para generacion ambulatoria de oxido nitrico. |
| US11577042B2 (en) | 2017-06-08 | 2023-02-14 | Case Western Reserve University | Vaporization system for delivery in a controlled concentration |
| US11672938B1 (en) | 2018-07-18 | 2023-06-13 | Vero Biotech LLC | Start-up protocols for nitric oxide delivery device |
| US11754538B1 (en) * | 2018-07-18 | 2023-09-12 | Vero Biotech Inc. | Method and apparatus for automatic calibration |
| WO2020232419A1 (en) | 2019-05-15 | 2020-11-19 | Third Pole, Inc. | Systems and methods for generating nitric oxide |
| WO2020232397A1 (en) | 2019-05-15 | 2020-11-19 | Third Pole, Inc. | Electrodes for nitric oxide generation |
| WO2021142472A1 (en) | 2020-01-11 | 2021-07-15 | Third Pole, Inc. | Systems and methods for nitric oxide generation with humidity control |
| WO2021252401A1 (en) * | 2020-06-07 | 2021-12-16 | Alti, Llc | Nitric oxide generation, delivery, and monitoring system |
| US20210395905A1 (en) | 2020-06-18 | 2021-12-23 | Third Pole, Inc. | Systems and methods for preventing and treating infections with nitric oxide |
| US11975139B2 (en) | 2021-09-23 | 2024-05-07 | Third Pole, Inc. | Systems and methods for delivering nitric oxide |
| KR102831194B1 (ko) * | 2022-12-22 | 2025-07-09 | 성균관대학교산학협력단 | 관류 mri 획득 방법 및 시스템 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3521865A (en) * | 1968-05-20 | 1970-07-28 | Du Pont | Generation of accurately known vapor concentrations by permeation |
| US3856204A (en) * | 1973-03-12 | 1974-12-24 | Ecology Board Inc | Gas emitting device |
| US4399942A (en) * | 1981-11-09 | 1983-08-23 | Gc Industries | Gas emitting device |
| US5324478A (en) * | 1987-08-14 | 1994-06-28 | American Air Liquide | Gas generating apparatus |
| US5653885A (en) * | 1990-07-13 | 1997-08-05 | Isco, Inc. | Apparatus and method for supercritical fluid extraction |
| US5156334A (en) * | 1990-08-15 | 1992-10-20 | Kimbell Charles L | Gas permeation system |
| US5396882A (en) * | 1992-03-11 | 1995-03-14 | The General Hospital Corporation | Generation of nitric oxide from air for medical uses |
| ATE204491T1 (de) * | 1993-04-17 | 2001-09-15 | Messer Griesheim Austria Ges M | Gerät zur kontrollierten zudosierung von no zur atemluft von patienten |
| GB9320978D0 (en) * | 1993-10-12 | 1993-12-01 | Higenbottam Timohy W | Nitric oxide treatment |
| US5558083A (en) * | 1993-11-22 | 1996-09-24 | Ohmeda Inc. | Nitric oxide delivery system |
| JP3142716B2 (ja) * | 1994-04-28 | 2001-03-07 | 裕一 石部 | 呼吸器への一酸化窒素の供給装置 |
| DE19612289A1 (de) * | 1996-03-28 | 1997-10-02 | Messer Griesheim Gmbh | Verfahren und Vorrichtung zur Minderung von Risiken bei der inhalativen NO-Therapie |
| US5692495A (en) * | 1996-04-02 | 1997-12-02 | The Boc Group, Inc. | Method and apparatus for the production of nitric oxide gas mixture |
| US5743251A (en) * | 1996-05-15 | 1998-04-28 | Philip Morris Incorporated | Aerosol and a method and apparatus for generating an aerosol |
| US6564656B1 (en) * | 1998-05-19 | 2003-05-20 | Markes International Limited | Sampling device |
| US6089229A (en) * | 1998-05-26 | 2000-07-18 | Datex-Ohmeda, Inc. | High concentration no pulse delivery device |
| US7516742B2 (en) * | 1999-11-24 | 2009-04-14 | Cardinal Health 207, Inc. | Method and apparatus for delivery of inhaled nitric oxide to spontaneous-breathing and mechanically-ventilated patients with intermittent dosing |
| MY136453A (en) * | 2000-04-27 | 2008-10-31 | Philip Morris Usa Inc | "improved method and apparatus for generating an aerosol" |
| EP2495004B1 (en) * | 2001-07-31 | 2014-04-16 | Philip Morris Products S.a.s. | Method and apparatus for generating a volatilized material |
| US6681769B2 (en) * | 2001-12-06 | 2004-01-27 | Crysalis Technologies Incorporated | Aerosol generator having a multiple path heater arrangement and method of use thereof |
| JP2007537267A (ja) * | 2004-05-11 | 2007-12-20 | センサーメディックス・コーポレイション | 一酸化窒素ガスの間欠的投与 |
| US7618594B2 (en) * | 2004-08-18 | 2009-11-17 | Geno Llc | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| AU2005277397B2 (en) * | 2004-08-18 | 2011-08-25 | VERO Biotech LLC. | Conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| US20070181126A1 (en) * | 2006-02-08 | 2007-08-09 | Tolmie Craig R | Method and apparatus for ventilating a patient with a breathing gas mixture formed from nitric oxide, air, and oxygen |
| US7947227B2 (en) | 2007-03-23 | 2011-05-24 | Geno Llc | Kit for the conversion of nitrogen dioxide (NO2) to nitric oxide (NO) |
| JP5554723B2 (ja) * | 2008-01-28 | 2014-07-23 | ゲノ エルエルシー | 二酸化窒素（ｎｏ２）から一酸化窒素（ｎｏ）への変換 |
| CA3037614A1 (en) * | 2008-07-24 | 2010-01-28 | Vero Biotech LLC | Methods for diagnosing and treating a heart condition in a patient |
| US8646445B2 (en) * | 2009-11-20 | 2014-02-11 | Geno Llc | Nitric oxide delivery system |
-
2011
- 2011-01-31 US US13/017,768 patent/US20110240019A1/en not_active Abandoned
- 2011-01-31 CA CA2788582A patent/CA2788582C/en active Active
- 2011-01-31 EP EP11737816.6A patent/EP2531249B1/en active Active
- 2011-01-31 ES ES11737816T patent/ES2873089T3/es active Active
- 2011-01-31 WO PCT/US2011/023172 patent/WO2011094684A1/en not_active Ceased
- 2011-01-31 JP JP2012551368A patent/JP5965845B2/ja not_active Expired - Fee Related
- 2011-01-31 AU AU2011210543A patent/AU2011210543B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2531249A4 (en) | 2014-08-27 |
| CA2788582A1 (en) | 2011-08-04 |
| ES2873089T3 (es) | 2021-11-03 |
| US20110240019A1 (en) | 2011-10-06 |
| EP2531249A1 (en) | 2012-12-12 |
| JP2013518615A (ja) | 2013-05-23 |
| JP5965845B2 (ja) | 2016-08-10 |
| AU2011210543B2 (en) | 2016-02-25 |
| AU2011210543A1 (en) | 2012-08-23 |
| WO2011094684A1 (en) | 2011-08-04 |
| EP2531249B1 (en) | 2021-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2788582C (en) | Nitric oxide delivery system | |
| US12383692B2 (en) | Systems and methods for synthesis of nitric oxide | |
| US20220016379A1 (en) | Delivery of high concentration nitric oxide | |
| US5839433A (en) | Nitric oxide treatment | |
| AU2013337351B2 (en) | Method of mixing gases including nitric oxide | |
| US10682486B1 (en) | Single treatment disposable nitric oxide delivery | |
| HK40041930A (en) | Systems and methods for synthesis of nitric oxide | |
| HK40041930B (en) | Systems and methods for synthesis of nitric oxide | |
| Gomez et al. | Delivery of inhaled nitric oxide from a 10% source by gas phase titration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20160129 |